Leigh Ragone

490 total citations
20 papers, 251 citations indexed

About

Leigh Ragone is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Leigh Ragone has authored 20 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 5 papers in Epidemiology and 4 papers in Virology. Recurrent topics in Leigh Ragone's work include HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (8 papers) and HIV Research and Treatment (4 papers). Leigh Ragone is often cited by papers focused on HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (8 papers) and HIV Research and Treatment (4 papers). Leigh Ragone collaborates with scholars based in United States, United Kingdom and South Africa. Leigh Ragone's co-authors include Howard Ball, John C. Whittaker, Thomas E. Hutson, Nan Bing, Mark S. Shaefer, Lon R. Cardon, Karen S. King, Lini Pandite, Paul de Souza and Vincent Mooser and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Pharmacology and Experimental Therapeutics and AIDS.

In The Last Decade

Leigh Ragone

17 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leigh Ragone United States 6 92 89 60 53 42 20 251
Aikaterini Nasi Sweden 9 18 0.2× 101 1.1× 71 1.2× 84 1.6× 51 1.2× 15 359
Gamal Hassoun Israel 9 15 0.2× 85 1.0× 50 0.8× 22 0.4× 61 1.5× 17 339
Dulanjalee Kariyawasam France 16 29 0.3× 225 2.5× 46 0.8× 32 0.6× 12 0.3× 37 571
Romana Petrovic United States 6 43 0.5× 153 1.7× 82 1.4× 11 0.2× 143 3.4× 13 352
Jiangyang Zhao China 11 17 0.2× 145 1.6× 16 0.3× 43 0.8× 42 1.0× 28 392
W. Cameron McGuire United States 8 26 0.3× 149 1.7× 8 0.1× 9 0.2× 90 2.1× 26 277
Evrim Anadol Germany 12 8 0.1× 143 1.6× 40 0.7× 171 3.2× 39 0.9× 17 428
Longhua Feng China 8 40 0.4× 112 1.3× 70 1.2× 15 0.3× 47 1.1× 11 259
Chenli Chang China 11 56 0.6× 72 0.8× 69 1.1× 37 0.7× 27 0.6× 16 252
Attilio Antonio Montano Bianchi Italy 5 79 0.9× 103 1.2× 28 0.5× 64 1.2× 58 1.4× 7 240

Countries citing papers authored by Leigh Ragone

Since Specialization
Citations

This map shows the geographic impact of Leigh Ragone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leigh Ragone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leigh Ragone more than expected).

Fields of papers citing papers by Leigh Ragone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leigh Ragone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leigh Ragone. The network helps show where Leigh Ragone may publish in the future.

Co-authorship network of co-authors of Leigh Ragone

This figure shows the co-authorship network connecting the top 25 collaborators of Leigh Ragone. A scholar is included among the top collaborators of Leigh Ragone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leigh Ragone. Leigh Ragone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anderson, Kim, Helena Rabie, Brian Eley, et al.. (2025). Mother‐child dyads living with HIV in the Western Cape, South Africa: Undetectable = Undetectable?. Journal of the International AIDS Society. 28(2). e26418–e26418.
2.
Cooney, Erin E., Sari L. Reisner, Tonia Poteat, et al.. (2025). Preference for Long-Acting Injectable PrEP Compared With Daily Oral PrEP Among Transgender Women in the U.S.: Findings From a Multisite Cohort. AJPM Focus. 4(2). 100313–100313.
3.
Ramgopal, Moti, Carolyn Brown, Gayathri Sridhar, et al.. (2025). 505. Real-World Use of Cabotegravir Long-Acting for Pre-Exposure Prophylaxis: Data from Trio Health Cohort. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations
4.
Anderson, Kim, Emma Kalk, Alexa Heekes, et al.. (2024). Factors associated with vertical transmission of HIV in the Western Cape, South Africa: a retrospective cohort analysis. Journal of the International AIDS Society. 27(3). e26235–e26235. 4 indexed citations
5.
6.
Cooney, Erin E., Sari L. Reisner, Tonia Poteat, et al.. (2024). Brief Report: Interest in Long-acting Injectable PrEP Among Transgender Women in Eastern and Southern United States. JAIDS Journal of Acquired Immune Deficiency Syndromes. 97(1). 19–25. 3 indexed citations
7.
Anderson, Kim, Gert U. van Zyl, Marvin Hsiao, et al.. (2024). HIV Drug Resistance in Newly Diagnosed Young Children in the Western Cape, South Africa. The Pediatric Infectious Disease Journal. 43(10). 970–976. 2 indexed citations
8.
Boulle, Andrew, Gayathri Sridhar, Mary‐Ann Davies, et al.. (2024). Factors associated with vertical transmission of HIV in the Western Cape, South Africa: a retrospective cohort analysis. UNC Libraries. 1 indexed citations
9.
Pierone, Gerald, Jennifer S Fusco, Vani Vannappagari, et al.. (2022). Dolutegravir/rilpivirine 2-drug regimen comparable to commonly prescribed 3-drug regimens up to 18-months in a real-world setting. Antiviral Therapy. 27(1). 2 indexed citations
10.
Vannappagari, Vani, Jessica D. Albano, Leigh Ragone, et al.. (2021). 74. Maternal Dolutegravir (DTG) Use During Pregnancy and Birth Outcomes: The Antiretroviral Pregnancy Registry (APR). Open Forum Infectious Diseases. 8(Supplement_1). S48–S49. 1 indexed citations
11.
Mounzer, Karam, Laurence Brunet, Christina Wyatt, et al.. (2021). To dose-adjust or not to dose-adjust: lamivudine dose in kidney impairment. AIDS. 35(8). 1201–1208. 4 indexed citations
12.
Pierone, Gerald, Cassidy Henegar, Jennifer S Fusco, et al.. (2019). Two‐drug antiretroviral regimens: an assessment of virologic response and durability among treatment‐experienced persons living with HIV in the OPERA® Observational Database. Journal of the International AIDS Society. 22(12). e25418–e25418. 4 indexed citations
13.
Mounzer, Karam, Ricky Hsu, Jennifer S Fusco, et al.. (2019). HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study. AIDS Research and Therapy. 16(1). 1–1. 38 indexed citations
14.
Nan, Cassandra, Mark S. Shaefer, J Oyee, et al.. (2018). Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials. Open Forum Infectious Diseases. 5(5). ofy086–ofy086. 29 indexed citations
15.
Vannappagari, Vani, Leigh Ragone, Cassidy Henegar, et al.. (2018). Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic Review. Antiviral Therapy. 24(6). 393–404. 13 indexed citations
16.
Lackey, Philip, Laurence Brunet, Jennifer S Fusco, et al.. (2018). 936. Body Fat Redistribution/Accumulation, Pancreatic Disorders, Musculoskeletal Disorders, IRIS, Severe Systemic Rash and Hypersensitivity Reactions Following Initiation of Commonly Prescribed Antiretrovirals. Open Forum Infectious Diseases. 5(suppl_1). S33–S34. 1 indexed citations
17.
Nan, Cassandra, et al.. (2017). Abacavir Use and Risk for Myocardial Infarction and Coronary Artery Disease: Updated Meta-analysis of Data from Clinical Trials. Open Forum Infectious Diseases. 4(suppl_1). S215–S215. 1 indexed citations
18.
Xu, Chun‐Fang, Nan Bing, Howard Ball, et al.. (2011). Pazopanib Efficacy in Renal Cell Carcinoma: Evidence for Predictive Genetic Markers in Angiogenesis-Related and Exposure-Related Genes. Journal of Clinical Oncology. 29(18). 2557–2564. 111 indexed citations
19.
Warren, Liling, Rachel A. Gibson, Lianna Ishihara, et al.. (2007). A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease. Parkinsonism & Related Disorders. 14(1). 77–80. 31 indexed citations
20.
Lowes, Simon, et al.. (2005). Multiple Components of 2,4-Dichlorophenoxyacetic Acid Uptake by Rat Choroid Plexus. Journal of Pharmacology and Experimental Therapeutics. 315(1). 136–143. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026